{
  "id": "5466ad18a19a6052",
  "title": "STAT+: Pharmalittle: We\u2019re reading about a change in obesity drug warnings, FDA approvals, and more",
  "description": "After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight loss drugs",
  "content": "After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight loss drugs",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/14/obesity-weight-suicide-illumina-antibiotics-pfizer-lilly-novo/?utm_campaign=rss",
  "published_at": "2026-01-14T14:20:24+00:00",
  "fetched_at": "2026-01-15T00:21:56.842948+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about a change in obesity drug warnings, FDA approvals, and more",
    "description": "After an agency review, the FDA asked drugmakers to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight loss drugs",
    "url": "https://www.statnews.com/pharmalot/2026/01/14/obesity-weight-suicide-illumina-antibiotics-pfizer-lilly-novo/?utm_campaign=rss",
    "published": "2026-01-14T14:20:24+00:00",
    "source": "STAT"
  }
}